DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Rosenstock J, Hollander P, Bhargava A. et al.
Similar efficacy and safety of LY2963 016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (ELEMENT 2 study).
Diabetes Obes Metabol 2015;
17: 734-741
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.